Clinical trial
S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the…
NCT00096213 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00096213 |
|---|---|
| Title | S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone |
| Official title | A Phase II Surgical Trial Of Intralesional Resection Of Low-Grade Intracompartmental Chondrosarcoma Of Bone |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH American College of Surgeons |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Procedure |
| Interventions | conventional surgery |
| Enrollment | 60 |
| Start date | Dec 1, 2004 |
| Primary completion | Apr 1, 2006 |
| Completion | Aug 1, 2009 |
| First posted | Nov 9, 2004 |
| Last update posted | Jan 18, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: